Integration of the Hamilton Microlab Star within HtL at AstraZeneca R&D Charnwood
News Jun 06, 2007
AstraZeneca requires automation of multiple applications across different processes. The use of the flexible and modular Microlab® Star enables AstraZeneca to use one instrument for diverse applications ranging from compound dilution to assay construction.
Working closely with AstraZeneca, Hamilton have designed a system that has greater capacity and functionality than AstraZeneca’s previous machines, enabling them to carry out accurate dilutions.
The Microlab STAR’s features like “Dual Liquid Level Detection”, “Monitored Air Dipslacement” and the CO-RE technology have increased the process safety remarkably at AstraZeneca.
The Hamilton Software has been incorporated into the in-house sample management system, which has enabled full sample/data tracking and an increase in the speed of sample processing.
The Microlab STAR system shows a decrease in assay variability and an increase in throughput and accuracy. As a result the Microlab STAR has become the benchmark instrument within HtL at AstraZeneca R&D Charnwood.
Researchers have developed an artificial enzymatic pathway for synthesizing isoprenoids, or terpenes, in E. coli. This shorter, more efficient, cost-effective and customizable pathway transforms E. coli into a factory that can produce terpenes for use in everything from cancer drugs to biofuels.READ MORE
2nd International Conference on Pharmaceutical Research & Innovations in Pharma Industry
May 30 - May 31, 2019